In this study, we report the differential sensitivity of high-grade human bladder cancer cell lines with mutant Hras (T24) or with mutant Kras (UMUC-3) versus wild-type Ras (HT1376) to FL118. This evidence concerns the gene HRAS and urinary bladder carcinoma.